Dechra Pharmaceuticals sees highest filings and grants during May in Q2 2024
Dechra Pharmaceuticals has been focused on protecting inventions in European Patent Office(EPO) with three publications in Q2 2024 The European Patent Office(EPO) Patent Office dominates